Jun Ren

64.1k total citations · 18 hit papers
926 papers, 38.2k citations indexed

About

Jun Ren is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Jun Ren has authored 926 papers receiving a total of 38.2k indexed citations (citations by other indexed papers that have themselves been cited), including 366 papers in Molecular Biology, 231 papers in Cardiology and Cardiovascular Medicine and 167 papers in Epidemiology. Recurrent topics in Jun Ren's work include Autophagy in Disease and Therapy (119 papers), Cardiovascular Function and Risk Factors (99 papers) and Adipose Tissue and Metabolism (82 papers). Jun Ren is often cited by papers focused on Autophagy in Disease and Therapy (119 papers), Cardiovascular Function and Risk Factors (99 papers) and Adipose Tissue and Metabolism (82 papers). Jun Ren collaborates with scholars based in United States, China and Canada. Jun Ren's co-authors include Yingmei Zhang, James R. Sowers, Hao Zhou, John J. Greer, Sreejayan Nair, Loren E. Wold, Pingjun Zhu, Rui Guo, Feng Dong and Asli F. Ceylan‐Isik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Jun Ren

889 papers receiving 37.6k citations

Hit Papers

Endoplasmic reticulum stress and unfolded protei... 2017 2026 2020 2023 2021 2017 2017 2018 2018 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases
    2021 473 citations Jun Ren, Yaguang Bi et al. profile →
  2. Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
    2017 424 citations Jun Ren et al. profile →
  3. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the Mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways
    2017 353 citations Jun Ren et al. profile →
  4. Pathogenesis of cardiac ischemia reperfusion injury is associated with CK2α-disturbed mitochondrial homeostasis via suppression of FUNDC1-related mitophagy
    2018 315 citations Jun Ren et al. profile →
  5. Targeting autophagy in obesity: from pathophysiology to management
    2018 273 citations Yingmei Zhang, Jun Ren et al. profile →
  6. Ferritinophagy and ferroptosis in the management of metabolic diseases
    2021 251 citations Jun Ren et al. profile →
  7. Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
    2021 237 citations Jun Ren, Yingmei Zhang et al. profile →
  8. Endoplasmic reticulum stress in liver diseases
    2022 224 citations Jun Ren et al. profile →
  9. Targeting autophagy in ischemic stroke: From molecular mechanisms to clinical therapeutics
    2021 220 citations Jun Ren et al. profile →
  10. Coronary microvascular injury in myocardial infarction: perception and knowledge for mitochondrial quality control
    2021 186 citations Jun Ren et al. profile →
  11. Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis
    2021 160 citations Jun Ren, Maolong Dong et al. profile →
  12. Autophagy and cancer drug resistance in dialogue: Pre-clinical and clinical evidence
    2023 152 citations Jun Ren et al. profile →
  13. Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity
    2022 152 citations Lin Wu, Litao Wang et al. profile →
  14. ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
    2022 147 citations Jun Ren et al. profile →
  15. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment
    2022 138 citations Jun Ren et al. profile →
  16. FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner
    2023 118 citations Yaguang Bi, Miyesaier Abudureyimu et al. profile →
  17. Copper homeostasis and cuproptosis in cardiovascular disease therapeutics
    2023 99 citations Jun Ren et al. profile →
  18. Inflammation in atherosclerosis: pathophysiology and mechanisms
    2024 89 citations Jun Ren et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jun Ren United States 98 15.9k 7.9k 7.5k 6.5k 4.0k 926 38.2k
Ryozo Nagai Japan 104 18.1k 1.1× 11.3k 1.4× 8.8k 1.2× 8.1k 1.2× 2.5k 0.6× 859 45.6k
Issei Komuro Japan 103 20.5k 1.3× 16.8k 2.1× 3.9k 0.5× 6.1k 0.9× 2.2k 0.5× 1.2k 42.9k
Masatsugu Hori Japan 91 10.7k 0.7× 11.3k 1.4× 4.0k 0.5× 3.0k 0.5× 3.1k 0.8× 537 33.2k
Pál Pacher United States 112 11.9k 0.7× 5.5k 0.7× 4.2k 0.6× 8.2k 1.3× 4.9k 1.2× 391 44.6k
Aimin Xu Hong Kong 97 15.0k 0.9× 5.0k 0.6× 12.4k 1.6× 10.3k 1.6× 1.4k 0.4× 524 33.4k
E. Dale Abel United States 90 13.9k 0.9× 9.5k 1.2× 3.4k 0.4× 7.9k 1.2× 1.3k 0.3× 278 28.7k
Csaba Szabó United States 117 16.1k 1.0× 4.8k 0.6× 3.8k 0.5× 11.5k 1.8× 5.1k 1.3× 682 51.1k
Ajay M. Shah United Kingdom 100 12.3k 0.8× 12.6k 1.6× 3.1k 0.4× 9.6k 1.5× 3.5k 0.9× 545 35.1k
Kenneth Walsh United States 113 28.3k 1.8× 9.8k 1.2× 11.2k 1.5× 13.1k 2.0× 2.5k 0.6× 462 54.0k
Toyoaki Murohara Japan 88 18.0k 1.1× 14.1k 1.8× 4.5k 0.6× 6.6k 1.0× 1.8k 0.5× 1.2k 45.3k

Countries citing papers authored by Jun Ren

Since Specialization
Citations

This map shows the geographic impact of Jun Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ren more than expected).

Fields of papers citing papers by Jun Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ren. The network helps show where Jun Ren may publish in the future.

Co-authorship network of co-authors of Jun Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Ren. A scholar is included among the top collaborators of Jun Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Ren. Jun Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Litao, Yuxin Du, Lin Wu, et al.. (2025). March2 Alleviates Aortic Aneurysm/Dissection by Regulating PKM2 Polymerization. Circulation Research. 136(8). e73–e93. 4 indexed citations
2.
Darko, Adjei Peter, et al.. (2024). Predicting determinants influencing user satisfaction with mental health app: An explainable machine learning approach based on unstructured data. Expert Systems with Applications. 249. 123647–123647. 6 indexed citations
3.
Wang, Yanjun, Guoliang Wang, Hao Gao, et al.. (2024). Analysis of risk factors, pathogenic bacteria characteristics, and drug resistance of postoperative surgical site infection in adults with limb fractures. Chinese Journal of Traumatology. 28(4). 241–251. 1 indexed citations
4.
Yu, Wenjun, Haixia Xu, Zhe Sun, et al.. (2023). TBC1D15 deficiency protects against doxorubicin cardiotoxicity via inhibiting DNA-PKcs cytosolic retention and DNA damage. Acta Pharmaceutica Sinica B. 13(12). 4823–4839. 9 indexed citations
5.
Mao, Yu, Jun Ren, & Lifang Yang. (2023). Advances of nanomedicine in treatment of atherosclerosis and thrombosis. Environmental Research. 238(Pt 2). 116637–116637. 13 indexed citations
6.
Rezaee, Aryan, Romina Rajabi, Ramin Khorrami, et al.. (2023). PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation. European Journal of Pharmacology. 955. 175909–175909. 13 indexed citations
7.
Ebrahimi, Nasim, Fatemeh Rezaei‐Tazangi, Payam Baziyar, et al.. (2023). The endocannabinoid system, a new gatekeeper in the pharmacology of human hepatocellular carcinoma. Environmental Research. 228. 115914–115914. 12 indexed citations
8.
Zou, Rongjun, Wanting Shi, Aslı F. Ceylan, et al.. (2023). Cardiomyocyte-specific deletion of endothelin receptor A (ETA) obliterates cardiac aging through regulation of mitophagy and ferroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1870(2). 166958–166958. 10 indexed citations
9.
Taheriazam, Afshin, Mohammad Arad Zandieh, Sepideh Mirzaei, et al.. (2023). Graphene oxide nanoarchitectures in cancer biology: Nano-modulators of autophagy and apoptosis. Journal of Controlled Release. 354. 503–522. 63 indexed citations
10.
Zhao, Huadong, Ying Chen, Qian Lu, et al.. (2023). Lycorine protects against septic myocardial injury by activating AMPK-related pathways. Free Radical Biology and Medicine. 197. 1–14. 12 indexed citations
11.
Sun, Mingming, Wenjing Zhang, Yaguang Bi, et al.. (2021). NDP52 Protects Against Myocardial Infarction-Provoked Cardiac Anomalies Through Promoting Autophagosome–Lysosome Fusion via Recruiting TBK1 and RAB7. Antioxidants and Redox Signaling. 36(16-18). 1119–1135. 15 indexed citations
12.
Ren, Jun, Xiuqing Ding, & John J. Greer. (2019). Activating α4β2 Nicotinic Acetylcholine Receptors Alleviates Fentanyl-induced Respiratory Depression in Rats. Anesthesiology. 130(6). 1017–1031. 16 indexed citations
13.
Wang, Boshi, Chao Shen, Li Y, et al.. (2019). Oridonin overcomes the gemcitabine resistant PANC-1/Gem cells by regulating GST pi and LRP/1 ERK/JNK signalling. SHILAP Revista de lepidopterología. 3 indexed citations
14.
Ren, Jun, et al.. (2013). Coadministration of the AMPAKINE CX717 with Propofol Reduces Respiratory Depression and Fatal Apneas. Anesthesiology. 118(6). 1437–1445. 42 indexed citations
15.
Ren, Jun. (2012). Identification and management of the Chinese vintage liquor. China Brewing. 1 indexed citations
16.
Ren, Jun, Yan–Ling Meng, Bin Hu, et al.. (2011). The effect of direct translocation across endosomes on the cytotoxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells. Biomaterials. 32(30). 7641–7650. 11 indexed citations
17.
Rose, Matthew F., Jun Ren, Kaashif A. Ahmad, et al.. (2009). Math1 Is Essential for the Development of Hindbrain Neurons Critical for Perinatal Breathing. Neuron. 64(3). 341–354. 135 indexed citations
18.
Ren, Jun, Xiuqing Ding, Gregory D. Funk, & John J. Greer. (2009). Ampakine CX717 Protects against Fentanyl-induced Respiratory Depression and Lethal Apnea in Rats. Anesthesiology. 110(6). 1364–1370. 104 indexed citations
19.
Wang, Tao, Jing Zhao, Jun Ren, et al.. (2007). Recombinant Immunoproapoptotic Proteins with Furin Site Can Translocate and Kill HER2-Positive Cancer Cells. Cancer Research. 67(24). 11830–11839. 45 indexed citations
20.
Ren, Jun, et al.. (2006). Ampakines Alleviate Respiratory Depression in Rats. American Journal of Respiratory and Critical Care Medicine. 174(12). 1384–1391. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryozo Nagai Breakdown of academic impact, for papers by Issei Komuro Breakdown of academic impact, for papers by Masatsugu Hori Breakdown of academic impact, for papers by Pál Pacher Breakdown of academic impact, for papers by Aimin Xu Breakdown of academic impact, for papers by E. Dale Abel Breakdown of academic impact, for papers by Csaba Szabó Breakdown of academic impact, for papers by Ajay M. Shah Breakdown of academic impact, for papers by Kenneth Walsh Breakdown of academic impact, for papers by Toyoaki Murohara
Rankless by CCL
2026